Cover Image

Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer

Yu Cao,1,* Huajian Zhu,1,* Ruoyu He,2 Limin Kong,3 Jiaan Shao,1 Rangxiao Zhuang,2 Jianjun Xi,2 Jiankang Zhang1 1School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, 310015, People’s Republic of China; 2Department of Pharmaceutical Preparation, Hangzhou Xixi Ho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cao Y (Author), Zhu H (Author), He R (Author), Kong L (Author), Shao J (Author), Zhuang R (Author), Xi J (Author), Zhang J (Author)
Format:	Book
Published:	Dove Medical Press, 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate
by: Daniela Brünnert, et al.
Published: (2023)

Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools
by: Paula Moyano, et al.
Published: (2023)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
by: Noah M. Merin, et al.
Published: (2014)

Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer
by: Muhammad Azhar Ud Din, et al.
Published: (2024)

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
by: Martin L. Dalefield, et al.
Published: (2022)

Periostin as a promising target of therapeutical intervention for colorectal cancer
by: Li Na Song, et al.
Published: (2014)

Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction
by: Maxwell Quinn, et al.
Published: (2024)

Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
by: Marta Pelon, et al.
Published: (2024)

Ubiquitin‐dependent regulation of MYC: A promising therapeutic target
by: Bryony G. Kennedy, et al.
Published: (2023)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
by: Won-Ji Ryu, et al.
Published: (2021)

Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment
by: Peng Song, et al.
Published: (2024)

The use of proteasome inhibitors in anti-cancer therapy
by: Marzena Teresa Baran, et al.
Published: (2020)

Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
by: Paula Iglesias-Matesanz, et al.
Published: (2024)

Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
by: Guidong Zhu, et al.
Published: (2021)

Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
by: Xing Z, et al.
Published: (2023)

Targeting copper metabolism: a promising strategy for cancer treatment
by: Ruimin Kong, et al.
Published: (2023)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
by: Cuicui Xiao, et al.
Published: (2020)

Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
by: Yuan Peng, et al.
Published: (2024)

From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
by: Yu Zhou, et al.
Published: (2024)

Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review
by: Maoyuan Zhao, et al.
Published: (2022)

Proteasome activity and subunit composition in endometrial hyperplasia and cancer
by: L. V. Spirina, et al.
Published: (2014)

Distinct Proteasome Subpopulations in the Alveolar Space of Patients with the Acute Respiratory Distress Syndrome
by: S. U. Sixt, et al.
Published: (2012)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
by: Yumeng Zhu, et al.
Published: (2022)

<i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant
by: Zhengqing Yu, et al.
Published: (2021)

Bioinformatic identification and experiment validation reveal 6 hub genes, promising diagnostic and therapeutic targets for Alzheimer's disease
by: Wenyuan Cao, et al.
Published: (2024)

Association of Obesity with Proteasomal Gene Polymorphisms in Children
by: Sarmite Kupca, et al.
Published: (2013)

Curcumin Targeting NF-κB/Ubiquitin-Proteasome-System Axis Ameliorates Muscle Atrophy in Triple-Negative Breast Cancer Cachexia Mice
by: Jin Zhang, et al.
Published: (2022)

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
by: Bingqing Shang, et al.
Published: (2023)

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases
by: Fan Yang, et al.
Published: (2024)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
by: Huiyan Sun, et al.
Published: (2023)

Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target
by: Dan Luo, et al.
Published: (2023)

Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor
by: Yang X, et al.
Published: (2022)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
by: Linyu Wu, et al.
Published: (2022)

HLA and proteasome expression body map
by: Sebastian Boegel, et al.
Published: (2018)

Targeting cancer with antibody-drug conjugates: Promises and challenges
by: Alexis Q. Dean, et al.
Published: (2021)

Ubiquitin Proteasome System Current Insights into Mechanism Cellular Regulation and Disease
Published: (2019)

The promising potential of piperlongumine as an emerging therapeutics for cancer
by: Dey Parama, et al.
Published: (2021)

Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
by: Zhaowei Zhu, et al.
Published: (2012)

PG F2alpha receptor: a promising therapeutic target for cardiovascular disease
by: Jian Zhang, et al.
Published: (2010)

Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity via targeting USP22
by: Yanyan Zhang, et al.
Published: (2024)